AQST - Aquestive Therapeutics to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 6 and Host Conference Call on November 7 at 8:00 a.m. ET | Benzinga
WARREN, N.J., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) (the "Company" or "Aquestive"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the third quarter ended September 30, 2023 and provide an update on recent developments in its business after market close on Monday, November 6, 2023.
Management will host a conference call for investors at 8:00 a.m. ET on Tuesday, November 7, 2023. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.
A live webcast of the call will be available on Aquestive's website at: Third Quarter 2023 Earnings Conference Call.
Following the call, a replay of the webcast will be available on the Investors section of the Company's website at https://investors.aquestive.com/events-and-presentations. The webcast will be archived for 30 days.
About Aquestive
Aquestive Therapeutics, Inc. (NASDAQ:AQST) ...